Rebif: payments to doctors
Payments that named Rebif as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $654K
- Providers
- 2,160
- Transactions
- 6,188
- Average per transaction
- $106
The per-transaction average — $106 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,160 providers the average total is $303, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| EMD Serono, Inc. | $648,717 | 99.3% |
| Merck Kgaa | $4,650 | 0.7% |
| Pfizer | $193 | 0.0% |